Device product
Custom procedural convenience kits and trays, Obstetrical & Gynecological use, labeled as: a) C-SECTION PACK, kit number FDCS01AA; b) C-SECTION PACK, kit number FDCS01AB; c) C-SECTION STERILE PACK, kit number HGCS68J; d) C-SECTION PACK, kit number HICS50H; e) C-SECTION PPS, kit number LLCI66; f) C-Section drape Pack, kit number RBCS12R; g) C-Section, kit number THCS49B; h) C-SECTION PACK (PS 020632), kit number UICS50AG;
Z-0830-2024
Product summary
- Event
- Event 93656
- Status
- Ongoing
- Classification
- Class II
- Quantity
- 1818 units
- Official record key
device-enforcement:Z-0830-2024
Official wording
Reason: During an internal investigation, ACS identified that several components were "piggybacked" to ACS trays and subjected to the ACS sterilization process. There is no supporting documentation stating the "piggybacked" components were assessed to determine if they were suitable for exposure to elevated temperatures for an extended period of time and further exposure to sterilization. As a result, the piggybacked components may (1) have a loss/lack of functionality, (2) loss of drug efficacy, if applicable, and (3) may have had higher than specified EO residuals.
Code information: a) FDCS01AA, UDI/DI 00191072179890, Lot Numbers: 708221, exp. 10/23/2023; 646221, exp. 12/20/2023; b) FDCS01AB, UDI/DI 00191072185273, Lot Numbers: 886231, exp. 4/24/2024; c) HGCS68J, UDI/DI none, Lot Numbers: 702221, exp. 10/22/2023; 654221, exp. 12/12/2023; 960231, exp. 2/9/2024; 903231, exp. 4/7/2024; d) HICS50H, UDI/DI none, Lot Numbers: 909221, exp. 4/1/2023; 835221, exp. 6/14/2023; 755221, exp. 9/2/2023; e) LLCI66, UDI/DI 00191072119025, Lot Numbers: 750221, exp. 9/7/2023; 727221, exp. 9/30/2023; 678221, exp. 11/9/2023; 994231, exp. 11/9/2023; 948231, exp. 11/9/2023; 926231, exp. 11/9/2023; f) RBCS12R, UDI/DI 00191072131812, Lot Numbers: 770221, exp. 8/18/2023; 695221, exp. 11/1/2023; g) THCS49B, UDI/DI 00191072153357, Lot Numbers: 770221, exp. 8/18/2023; h) UICS50AG, UDI/DI none, Lot Numbers: 679221, exp. 11/17/2023; 946231, exp. 2/23/2024; 876231, exp. 5/4/2024;
Distribution pattern: US Nationwide distribution.
Derived failure modes
-
Unknown
During an internal investigation, ACS identified that several components were "piggybacked" to ACS trays and subjected to the ACS sterilization process. There is no supporting documentation stating the "piggybacked" components were assessed to determine if they were suitable for exposure to elevated temperatures for an extended period of time and further exposure to sterilization. As a result, the piggybacked components may (1) have a loss/lack of functionality, (2) loss of drug efficacy, if applicable, and (3) may have had higher than specified EO residuals.